KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eaton (ETN) Research & Development (2016 - 2025)

Eaton (ETN) has disclosed Research & Development for 14 consecutive years, with $203.0 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 1.0% to $203.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $796.0 million through Dec 2025, changed 0.38% year-over-year, with the annual reading at $797.0 million for FY2025, 0.38% changed from the prior year.
  • Research & Development for Q4 2025 was $203.0 million at Eaton, roughly flat from $203.0 million in the prior quarter.
  • The five-year high for Research & Development was $207.0 million in Q3 2024, with the low at $148.0 million in Q1 2021.
  • Average Research & Development over 5 years is $181.2 million, with a median of $187.0 million recorded in 2023.
  • Peak annual rise in Research & Development hit 22.22% in 2021, while the deepest fall reached 3.27% in 2021.
  • Over 5 years, Research & Development stood at $162.0 million in 2021, then increased by 3.09% to $167.0 million in 2022, then grew by 20.36% to $201.0 million in 2023, then changed by 0.0% to $201.0 million in 2024, then increased by 1.0% to $203.0 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $203.0 million, $203.0 million, and $192.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.